Alessandro D'Agnolo
Quick facts
Phase 2 pipeline
- 18F-PSMA · Oncology
18F-PSMA is a fluorine-18 labeled radiotracer that binds to prostate-specific membrane antigen (PSMA) for positron emission tomography (PET) imaging of PSMA-expressing tumors.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: